Type 2 diabetes drug shows promise against obesity, study suggests. But it’s expensive.
Researchers found that on average, individuals who received doses of semaglutide lost close to 15% of their body weight.
Obesity increases the risk of severe illness from COVID-19 and other health problems, such as heart disease, diabetes, high blood pressure and certain cancers. (Dreamstime/TNS)Read morePABLO ALCALA / MCT
